Woodline Partners »

Tectonic Therapeutic shares owned by Woodline Partners

Quarter-by-quarter ownership of Tectonic Therapeutic (TECX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Tectonic Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Tectonic Therapeutic held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tectonic Therapeutic by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 65k 30.30

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Tectonic Therapeutic

Vida Ventures Advisors
EcoR1 Capital
5AM Venture Management
Farallon Capital Management
Atlas Venture Life Science Advisors
Ikarian Capital
BML Capital Management
Vanguard Group
Verition Fund Management
BlackRock
Aisling Capital Management
Tang Capital Management
Geode Capital Management
Woodline Partners
Susquehanna International

View all funds holding Tectonic Therapeutic